S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
pixel
Log in
OTCMKTS:APNHY

Aspen Pharmacare Competitors

$9.55
-0.06 (-0.62 %)
(As of 03/5/2021 11:36 AM ET)
Add
Compare
Today's Range
$9.55
Now: $9.55
$9.55
50-Day Range
$8.82
MA: $9.61
$10.03
52-Week Range
$4.86
Now: $9.55
$10.09
Volume735 shs
Average Volume3,775 shs
Market Capitalization$4.36 billion
P/E Ratio11.65
Dividend YieldN/A
Beta1.53

Competitors

Aspen Pharmacare (OTCMKTS:APNHY) Vs. OMRNY, DWHHF, OMVJF, SGTZY, NNGRY, and ERFSF

Should you be buying APNHY stock or one of its competitors? Companies in the industry of "private households" are considered alternatives and competitors to Aspen Pharmacare, including OMRON (OMRNY), Deutsche Wohnen (DWHHF), OMV Aktiengesellschaft (OMVJF), Surgutneftegas Public Joint Stock (SGTZY), NN Group (NNGRY), and Eurofins Scientific (ERFSF).

OMRON (OTCMKTS:OMRNY) and Aspen Pharmacare (OTCMKTS:APNHY) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, earnings, risk and dividends.

Analyst Recommendations

This is a summary of current ratings and target prices for OMRON and Aspen Pharmacare, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
OMRON01002.00
Aspen Pharmacare0000N/A

Insider and Institutional Ownership

0.9% of OMRON shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares OMRON and Aspen Pharmacare's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OMRON$6.24 billion2.67$689.03 millionN/AN/A
Aspen Pharmacare$2.49 billion1.75$300.36 million$0.8211.65

OMRON has higher revenue and earnings than Aspen Pharmacare.

Volatility and Risk

OMRON has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Comparatively, Aspen Pharmacare has a beta of 1.53, suggesting that its share price is 53% more volatile than the S&P 500.

Profitability

This table compares OMRON and Aspen Pharmacare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
OMRONN/AN/AN/A
Aspen PharmacareN/AN/AN/A

Summary

OMRON beats Aspen Pharmacare on 4 of the 5 factors compared between the two stocks.

Deutsche Wohnen (OTCMKTS:DWHHF) and Aspen Pharmacare (OTCMKTS:APNHY) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations and dividends.

Risk & Volatility

Deutsche Wohnen has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500. Comparatively, Aspen Pharmacare has a beta of 1.53, meaning that its stock price is 53% more volatile than the S&P 500.

Valuation and Earnings

This table compares Deutsche Wohnen and Aspen Pharmacare's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Deutsche Wohnen$937.88 million17.52$1.71 billion$4.2810.67
Aspen Pharmacare$2.49 billion1.75$300.36 million$0.8211.65

Deutsche Wohnen has higher earnings, but lower revenue than Aspen Pharmacare. Deutsche Wohnen is trading at a lower price-to-earnings ratio than Aspen Pharmacare, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Deutsche Wohnen and Aspen Pharmacare, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Deutsche Wohnen20402.33
Aspen Pharmacare0000N/A

Profitability

This table compares Deutsche Wohnen and Aspen Pharmacare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Deutsche Wohnen145.51%9.32%4.20%
Aspen PharmacareN/AN/AN/A

Summary

Deutsche Wohnen beats Aspen Pharmacare on 8 of the 10 factors compared between the two stocks.

OMV Aktiengesellschaft (OTCMKTS:OMVJF) and Aspen Pharmacare (OTCMKTS:APNHY) are both oils/energy companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, valuation, risk and earnings.

Risk and Volatility

OMV Aktiengesellschaft has a beta of 1.03, suggesting that its stock price is 3% more volatile than the S&P 500. Comparatively, Aspen Pharmacare has a beta of 1.53, suggesting that its stock price is 53% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations and price targets for OMV Aktiengesellschaft and Aspen Pharmacare, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
OMV Aktiengesellschaft0000N/A
Aspen Pharmacare0000N/A

Earnings & Valuation

This table compares OMV Aktiengesellschaft and Aspen Pharmacare's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OMV Aktiengesellschaft$26.28 billion0.62$1.96 billion$5.578.94
Aspen Pharmacare$2.49 billion1.75$300.36 million$0.8211.65

OMV Aktiengesellschaft has higher revenue and earnings than Aspen Pharmacare. OMV Aktiengesellschaft is trading at a lower price-to-earnings ratio than Aspen Pharmacare, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares OMV Aktiengesellschaft and Aspen Pharmacare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
OMV Aktiengesellschaft-1.64%4.61%1.83%
Aspen PharmacareN/AN/AN/A

Summary

OMV Aktiengesellschaft beats Aspen Pharmacare on 5 of the 9 factors compared between the two stocks.

Aspen Pharmacare (OTCMKTS:APNHY) and Surgutneftegas Public Joint Stock (OTCMKTS:SGTZY) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, dividends, earnings, valuation, profitability, risk and institutional ownership.

Profitability

This table compares Aspen Pharmacare and Surgutneftegas Public Joint Stock's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Aspen PharmacareN/AN/AN/A
Surgutneftegas Public Joint StockN/AN/AN/A

Risk and Volatility

Aspen Pharmacare has a beta of 1.53, suggesting that its share price is 53% more volatile than the S&P 500. Comparatively, Surgutneftegas Public Joint Stock has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500.

Insider & Institutional Ownership

0.0% of Surgutneftegas Public Joint Stock shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Aspen Pharmacare and Surgutneftegas Public Joint Stock's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aspen Pharmacare$2.49 billion1.75$300.36 million$0.8211.65
Surgutneftegas Public Joint Stock$28.13 billion0.60$1.65 billionN/AN/A

Surgutneftegas Public Joint Stock has higher revenue and earnings than Aspen Pharmacare.

Analyst Ratings

This is a breakdown of current ratings for Aspen Pharmacare and Surgutneftegas Public Joint Stock, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Aspen Pharmacare0000N/A
Surgutneftegas Public Joint Stock0000N/A

Summary

Surgutneftegas Public Joint Stock beats Aspen Pharmacare on 3 of the 5 factors compared between the two stocks.

Aspen Pharmacare (OTCMKTS:APNHY) and NN Group (OTCMKTS:NNGRY) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, dividends, profitability and institutional ownership.

Analyst Recommendations

This is a summary of current recommendations and price targets for Aspen Pharmacare and NN Group, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Aspen Pharmacare0000N/A
NN Group05502.50

Insider and Institutional Ownership

0.4% of NN Group shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Risk and Volatility

Aspen Pharmacare has a beta of 1.53, suggesting that its stock price is 53% more volatile than the S&P 500. Comparatively, NN Group has a beta of 1.07, suggesting that its stock price is 7% more volatile than the S&P 500.

Profitability

This table compares Aspen Pharmacare and NN Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Aspen PharmacareN/AN/AN/A
NN GroupN/AN/AN/A

Valuation & Earnings

This table compares Aspen Pharmacare and NN Group's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aspen Pharmacare$2.49 billion1.75$300.36 million$0.8211.65
NN Group$22.92 billion0.70$2.20 billionN/AN/A

NN Group has higher revenue and earnings than Aspen Pharmacare.

Summary

NN Group beats Aspen Pharmacare on 4 of the 7 factors compared between the two stocks.

Eurofins Scientific (OTCMKTS:ERFSF) and Aspen Pharmacare (OTCMKTS:APNHY) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, valuation and analyst recommendations.

Profitability

This table compares Eurofins Scientific and Aspen Pharmacare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Eurofins ScientificN/AN/AN/A
Aspen PharmacareN/AN/AN/A

Volatility & Risk

Eurofins Scientific has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Comparatively, Aspen Pharmacare has a beta of 1.53, meaning that its share price is 53% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings for Eurofins Scientific and Aspen Pharmacare, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Eurofins Scientific20402.33
Aspen Pharmacare0000N/A

Valuation and Earnings

This table compares Eurofins Scientific and Aspen Pharmacare's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Eurofins Scientific$5.19 billion3.01$218.74 million$2.2638.76
Aspen Pharmacare$2.49 billion1.75$300.36 million$0.8211.65

Aspen Pharmacare has lower revenue, but higher earnings than Eurofins Scientific. Aspen Pharmacare is trading at a lower price-to-earnings ratio than Eurofins Scientific, indicating that it is currently the more affordable of the two stocks.

Summary

Eurofins Scientific beats Aspen Pharmacare on 5 of the 7 factors compared between the two stocks.


Aspen Pharmacare Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
OMRON logo
OMRNY
OMRON
1.0$80.79-1.6%$16.66 billion$6.24 billion0.00Decrease in Short Interest
News Coverage
Deutsche Wohnen logo
DWHHF
Deutsche Wohnen
0.9$45.68-4.8%$16.43 billion$937.88 million13.36
OMV Aktiengesellschaft logo
OMVJF
OMV Aktiengesellschaft
1.0$49.82-0.0%$16.27 billion$26.28 billion-50.32Decrease in Short Interest
News Coverage
SGTZY
Surgutneftegas Public Joint Stock
0.1$4.70-4.3%$16.08 billion$28.13 billion0.00Gap Down
NN Group logo
NNGRY
NN Group
1.1$24.17-1.2%$15.96 billion$22.92 billion7.50Upcoming Earnings
Analyst Report
Eurofins Scientific logo
ERFSF
Eurofins Scientific
0.9$87.60-2.9%$15.59 billion$5.19 billion38.76Upcoming Earnings
bioMérieux logo
BMXMF
bioMérieux
0.5$129.50-1.2%$15.33 billion$3.00 billion50.19Increase in Short Interest
Atlantia logo
ATASY
Atlantia
0.6$9.28-0.2%$15.33 billion$14.13 billion103.11
Rakuten logo
RKUNY
Rakuten
0.6$10.59-1.6%$15.19 billion$11.60 billion-17.36Analyst Upgrade
Decrease in Short Interest
Chow Tai Fook Jewellery Group logo
CJEWY
Chow Tai Fook Jewellery Group
1.2$14.43-1.5%$14.43 billion$7.26 billion39.00News Coverage
MonotaRO logo
MONOY
MonotaRO
1.1$57.35-1.0%$14.37 billion$1.21 billion127.45Upcoming Earnings
Kumba Iron Ore logo
KIROY
Kumba Iron Ore
0.8$14.80-4.7%$14.30 billion$4.45 billion0.00Upcoming Earnings
Decrease in Short Interest
Covestro logo
COVTY
Covestro
1.1$36.59-0.1%$14.14 billion$13.90 billion62.02Increase in Short Interest
Carrefour logo
CRRFY
Carrefour
1.1$3.39-1.2%$13.86 billion$81.09 billion13.04
Renault logo
RNLSY
Renault
0.7$9.32-1.6%$13.78 billion$62.21 billion-77.67Analyst Upgrade
Increase in Short Interest
Davide Campari-Milano logo
DVDCF
Davide Campari-Milano
1.0$11.94-0.0%$13.75 billion$2.06 billion45.92Increase in Short Interest
Edenred logo
EDNMY
Edenred
0.4$27.74-2.6%$13.68 billion$1.82 billion0.00Analyst Report
Increase in Short Interest
Sompo logo
SMPNY
Sompo
1.7$18.29-0.2%$13.66 billion$34.60 billion10.39Upcoming Earnings
News Coverage
Terna - Rete Elettrica Nazionale Società per Azioni logo
TEZNY
Terna - Rete Elettrica Nazionale Società per Azioni
0.6$20.43-0.3%$13.64 billionN/A0.00Increase in Short Interest
Nitto Denko logo
NDEKY
Nitto Denko
1.2$42.30-0.8%$13.43 billion$6.82 billion30.43News Coverage
Yara International ASA logo
YARIY
Yara International ASA
1.5$24.84-1.7%$13.32 billion$12.94 billion20.53
Schroders logo
SHNWF
Schroders
0.9$46.75-5.0%$13.21 billion$3.24 billion18.48Analyst Upgrade
News Coverage
Persimmon logo
PSMMY
Persimmon
1.6$82.42-0.9%$13.15 billion$4.66 billion12.00Analyst Report
Analyst Revision
News Coverage
Randstad logo
RANJY
Randstad
1.3$34.96-0.4%$12.82 billion$26.52 billion44.82Dividend Announcement
Analyst Revision
Air China logo
AIRYY
Air China
1.0$17.55-0.0%$12.75 billion$33.09 billion-8.01Decrease in Short Interest
HRELY
Haier Electronics Group
0.7$44.88-0.0%$12.64 billion$10.98 billion21.27
ZTE logo
ZTCOY
ZTE
1.4$5.42-3.1%$12.49 billion$13.00 billion15.93Decrease in Short Interest
Gap Up
SEGRO logo
SEGXF
SEGRO
0.5$12.43-4.2%$12.47 billion$552.27 million0.00
Smurfit Kappa Group logo
SMFKY
Smurfit Kappa Group
1.5$48.23-0.1%$12.44 billion$10.13 billion15.81Increase in Short Interest
Bureau Veritas logo
BVRDF
Bureau Veritas
1.0$27.56-0.0%$12.31 billion$5.71 billion24.17
Croda International logo
COIHY
Croda International
1.0$43.23-2.2%$12.06 billion$1.76 billion36.64Analyst Report
Decrease in Short Interest
Analyst Revision
News Coverage
Spirax-Sarco Engineering logo
SPXSF
Spirax-Sarco Engineering
0.7$163.35-0.0%$12.03 billion$1.59 billion48.33Upcoming Earnings
Mondi logo
MONDY
Mondi
1.6$48.94-0.2%$11.88 billion$8.14 billion12.68Analyst Report
ageas SA/NV logo
AGESY
ageas SA/NV
1.3$60.90-2.4%$11.85 billion$16.91 billion9.41Analyst Report
Brenntag logo
BNTGY
Brenntag
1.3$15.32-0.5%$11.83 billion$14.36 billion22.53Upcoming Earnings
Analyst Upgrade
Halma logo
HLMAF
Halma
0.8$31.07-3.3%$11.79 billion$1.70 billion42.56
Brambles logo
BXBLY
Brambles
1.4$15.67-1.4%$11.52 billion$4.73 billion24.11Dividend Announcement
AJINY
Ajinomoto
0.5$20.71-1.7%$11.37 billion$10.12 billion0.00
Davide Campari-Milano logo
DVDCY
Davide Campari-Milano
1.3$9.85-5.2%$11.34 billion$2.06 billion37.88News Coverage
COSCO SHIPPING logo
CICOY
COSCO SHIPPING
0.8$5.49-2.7%$11.22 billion$21.78 billion68.63
COIHD
Croda International
1.2$43.23-2.2%$11.11 billion$1.85 billion33.51
DiaSorin logo
DSRLF
DiaSorin
0.8$198.00-0.0%$11.08 billion$791.17 million55.15
Disco logo
DSCSY
Disco
1.3$61.44-0.0%$11.07 billion$1.30 billion38.40Upcoming Earnings
Analyst Downgrade
Gap Up
Tingyi (Cayman Islands) logo
TCYMF
Tingyi (Cayman Islands)
0.7$1.95-0.0%$10.97 billion$8.97 billion21.67
RCDTF
Recordati Industria Chimica e Farmaceutica
0.8$51.69-0.0%$10.81 billion$1.64 billion24.85
Burberry Group logo
BURBY
Burberry Group
0.9$26.32-2.6%$10.65 billion$3.37 billion26.05Increase in Short Interest
GN Store Nord A/S logo
GNNDY
GN Store Nord A/S
1.1$219.95-2.1%$10.43 billion$1.89 billion49.21Upcoming Earnings
High Trading Volume
Increase in Short Interest
Barratt Developments logo
BTDPY
Barratt Developments
1.1$20.34-1.3%$10.36 billion$4.24 billion20.97
Aisin Seiki logo
ASEKY
Aisin Seiki
1.3$35.06-0.7%$10.33 billion$34.89 billion-23.22Upcoming Earnings
High Trading Volume
Analyst Revision
News Coverage
CLLDY
CapitaLand
1.0$4.94-2.2%$10.31 billion$4.57 billion7.84Upcoming Earnings
News Coverage
This page was last updated on 3/7/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.